Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950144-98-003731
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
5
Period of Report
1997-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 THERAPEUTIC ANTIBODIES, INC. 10-K405 197096
2 1997 STOCK OPTION PLAN EX-10.12 51131
3 DISTRIBUTION AGREEMENT EX-10.22 69022
4 SUBSIDIARIES EX-21.1 634
5 FINANCIAL DATA SCHEDULE EX-27.1 2316
  Complete submission text file 0000950144-98-003731.txt   322079
Mailing Address 1500 21ST AVE SOUTH STE 310 NASHVILLE TN 37212
Business Address 1500 21ST AVE SOUTH STE 310 NASHVILLE TN 37212 6153271027
THERAPEUTIC ANTIBODIES INC /DE (Filer) CIK: 0000944744 (see all company filings)

EIN.: 621212485 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-25978 | Film No.: 98580441
SIC: 8071 Services-Medical Laboratories